Ospedale Pediatrico bambino Gesu'
Roma 146
3 studies enrolling now · 21 studies all time
What they study most
Acute Graft-versus-host Disease, Adenovirus, Ards, Becker Muscular Dystrophy, Cystic Fibrosis, DNA Virus Infections, Diabetes Mellitus, Type 2, Differentiated Thyroid Cancer (DTC), Digestive System Diseases, Duchenne Muscular Dystrophy, Epileptic Encephalopathy, GRIN-related Neurodevelopmental Disorder
Studies at this site
- A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy — Recruiting now
- Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder — Recruiting now
- Clinical Decision Support Tool in PARDS Pilot Study — Recruiting now
- An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC) — Completed
- A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow — Running, not enrolling
- A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day — Running, not enrolling
- STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss — Running, not enrolling
- A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4) — Completed
- Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects — Stopped early
- Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) — Completed
- A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) — Completed
- Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma — Completed
- A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms — Withdrawn before enrolling
- Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis — Completed
- Phase 3 Alogliptin Pediatric Study — Completed
- Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria — Stopped early
- Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition — Completed
- The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation — Stopped early
- Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) — Stopped early
- Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months — Withdrawn before enrolling
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis B — Completed